Items tagged with Diagnostics

Unitaid commits US $21.4 million to the WHO prequalification programme (post)

Geneva, 9 October 2017 – Unitaid is investing a further US$ 21.4 million in the World Health Organization’s (WHO) prequalification programme for medicines and diagnostics.

QIAGEN launches fourth-generation QuantiFERON®-TB Gold Plus in the U.S. (post)

Germantown, Maryland, and Hilden, Germany, October 5, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of QuantiFERON^®-TB Gold Plus (QFT^®-Plus), the fourth generation of its leading blood test for tuberculosis (TB) infection. QFT-Plus kits will be available on October 9, 2017 for diagnostic use following U.S. Food and Drug Administration approval in June.

Groundbreaking, web-based pathway to guide innovators as they develop new TB diagnostics and adjunct technologies (post)

9 October 2017 - Guadalajara, Mexico - Global health organizations are proud to announce the launch of the very first, web-based pathway for tuberculosis (TB) diagnostics and adjunct technologies.

Accuracy of negative tuberculin skin test in predicting in-hospital TB mortality (post)

SAN DIEGO, October 06, 2017 — Malnutrition, increasing age, and negative tuberculin skin test (TST) results are factors that may weaken the immune system and subsequently increase in-hospital mortality in hospitalized people with tuberculosis (TB), according to results from a retrospective study presented at IDWeek 2017.

Highlights from the 48th Union World Conference on Lung Health (post)

New tests to diagnose TB in children? (post)

For children with suspected tuberculosis (TB), diagnosis is difficult and can often be painful and complicated. In a vulnerable population where many kids are being missed new diagnostics are critical. Preliminary results from a South African trial have given experts in the field, and patients, a glimmer of hope.

Diagnostic revolution targets TB, other deadly diseases (post)

Skeletal remains dating to the Neolithic era in Egypt bear tell-tale traces of tuberculosis (TB)—a disease that is estimated to have killed a billion people in the last two centuries alone.

India moving forward in research towards new tools for TB (post)

-- Indigenously developed point-of-care (POC) molecular diagnostic test validated through multi-centric studies and found to be comparable with internationally approved molecular diagnostic test

Automated molecular assay detects drug-resistant TB (post)

An automated molecular assay can detect Mycobacterium tuberculosis with resistance to drugs directly from sputum specimens, according to a study published the New England Journal of Medicine.

Improved diagnostics fail to halt the rise of tuberculosis (post)

Seven years ago, the global community of researchers, health-care workers and activists battling tuberculosis was euphoric. A landmark 2010 trial showed that a new genetic test was highly effective at diagnosing TB, prompting hopes that countries could soon finally control the disease, which killed 1.45 million that year. The World Health Organization (WHO), promptly endorsed the test, called GeneXpert, and promoted its roll-out around the globe to replace a microscope-based test that missed half of all cases.